MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/acm2.14550

Медицинская библиотека · Journal of applied clinical medical physics · 2024

Enhancing safety: Multi-institutional FMEA and FTA on 177 Lu $^{177}{\rm Lu}$ -based radio-pharmaceutical therapy.

George Siju C, Aguirre Santiago, Maughan Nichole M, Tolakanahalli Ranjini, Samuel E James Jebaseelan, Gallo Sven L, Zoberi Jacqueline E, Lee Yongsook C

СтатьяМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

PURPOSE: This study investigates potential failure modes and conducts failure mode and effects analysis (FMEA) and fault tree analysis (FTA) on the administration of 177 Lu $^{177}{\rm Lu}$ DOTATATE (LUTATHERA) and 177 Lu $^{177}{\rm Lu}$ PSMA-617 (PLUVICTO). The quality management (QM) process in radiopharmaceutical therapies (RPTs) requires collaboration between nuclear medicine (NM) and radiation oncology (RO) departments. As part of a multi-institutional study, we surveyed various departments to identify and analyze failure modes, leading to a proposed comprehensive QM program. RPT teams in RO or NM clinics can benefit from this study by continually improving their practice.

METHODS

We reviewed the literature to investigate the administration of Pluvicto and Lutathera, focusing on prospective procedural failures and potential failure modes (PFMs) and their outcomes. We distributed an FMEA survey to multiple experienced centers in 177 Lu $^{177}{\rm Lu}$ -based RPTs and calculated risk priority number (RPN) for various PFM. We conducted an FTA using this information to pinpoint the root causes of potential failures.

RESULTS

The findings from the literature review and survey responses on the prospective study have identified several critical areas at risk of failure. These areas include non-optimized treatment delivery, inadequate patient monitoring, and lack of safety training, leading to radiation contamination from the dose excreted by the patients after treatment administration. A segmented FTA was created based on the FMEA results, focusing on radiation contamination with a high RPN value.

CONCLUSION

By identifying the root causes of failures and proposing targeted improvements to the existing QM measures, this analysis enhances safety in treatment delivery of 177 Lu $^{177}{\rm Lu}$ -based RPTs. Given the limited number of prospective risk analysis studies in RPTs, our research addresses the necessity for more such studies and recommends methods to apply this study to other RPTs.

Для цитирования: George Siju C, Aguirre Santiago, Maughan Nichole M, Tolakanahalli Ranjini, Samuel E James Jebaseelan, Gallo Sven L, Zoberi Jacqueline E, Lee Yongsook C. Enhancing safety: Multi-institutional FMEA and FTA on 177 Lu $^{177}{\rm Lu}$ -based radio-pharmaceutical therapy.. Journal of applied clinical medical physics. 2024. DOI: 10.1002/acm2.14550.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.